INTERNATIONAL IMMUNOPHARMACOLOGY-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2182438, encodeId=a56c21824388d, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：胃癌;肿瘤免疫 经验分享：这个杂志真的好慢好慢，外审一个月，大修一个月，修回with editor一整个月，然后又送外审，十几天，RRC两周了，还没消息，等的我花都谢了。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=253, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11f06507596, createdName=ms9000001327347856, createdTime=Thu Jan 18 15:39:11 CST 2024, time=2024-01-18, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2103457, encodeId=1bd8210345ee0, content=2022.9.27 提交 2022.9.30 外审中间日期变了几次 2022.10.29 大修给了六十多条意见，但是都不是特别犀利 2022.11.13 修回再次under review 2022.11.28 接收 很nice的期刊，速度快，编辑人也很友善, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b6a8289282, createdName=ms5000001856769052, createdTime=Wed Nov 30 09:54:09 CST 2022, time=2022-11-30, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=590348, encodeId=89cf590348da, content=请问提供了原始wb图片了吗？怎么处理的？ lekai726 2020-04-03 发表:: 接收率：约50% 审稿时间：约2个月很快，我可能是高分低投了，因为赶时间毕业，四五分的文章内容所以也没提太多问题，一个月就接收了，另外说下编辑，真的人超级好，对中国人非常好lekai726 2020-04-03 00:00:00 发表: 很快，我可能是高分低投了，因为赶时间毕业，四五分的文章内容所以也没提太多问题，一个月就接收了，另外说下编辑，真的人超级好，对中国人非常好, beContent=lekai726 2020-04-03 发表:: 接收率：约50% 审稿时间：约2个月很快，我可能是高分低投了，因为赶时间毕业，四五分的文章内容所以也没提太多问题，一个月就接收了，另外说下编辑，真的人超级好，对中国人非常好, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=32b75167275, createdName=146cc187m12暂无昵称, createdTime=Wed May 06 00:00:00 CST 2020, time=2020-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207706, encodeId=b603120e706b0, content=被预警了，要摘星了，IF要涨了，不好投了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e6935111920, createdName=14618cfam12暂无昵称, createdTime=Fri Apr 01 00:07:27 CST 2022, time=2022-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2201187, encodeId=53f9220118e8e, content=2024-03-26投稿 03-26 with editor 03-26 under review 03-28 under review 有一个审稿人接受审稿 04-15 under review 有一个审稿人完成审稿 编辑没有再邀请审稿人，是否能催一下？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2448342932, createdName=ms9000000167770666, createdTime=Tue Apr 30 09:01:21 CST 2024, time=2024-04-30, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2170197, encodeId=1dd921e019749, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：免疫;炎症 经验分享：10.05投稿 10.11送审 10.26审稿人完成审稿 10.31给出大修 11.05修回 11.15审稿人完成审稿 11.16接收 11.19清样 10.22在线发表来还愿啦！效率很高的一个杂志，编辑和两位审稿人都很友好。修改后文章整体水平提升很大。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/YConHRH5GCtcFEWO7xCkB10VsePH8PlzvattQoVRIQ7KJg26g6PvbkD8nE6Gsic5Nub2HzA4TsvkTQqEYUoz7pw/132, createdBy=288f2160779, createdName=liyu5975, createdTime=Wed Nov 22 11:16:56 CST 2023, time=2023-11-22, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2185279, encodeId=f3ae21852e9df, content=之前投过一次，带着返修意见被拒了，补了一些实验 重新又投了 Nov 29, 2023 Submission Nov 29, 2023 With Editor Dec 04, 2023 Under Review Dec 22, 2023 Major Revise Jan 10, 2024 Submission Jan 10, 2024 Under Review Jan 18, 2024 Completed-Accept 祝大家好运！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3bc32405040, createdName=12362582m11(暂无昵称), createdTime=Thu Feb 01 19:11:16 CST 2024, time=2024-02-01, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2186928, encodeId=2e112186928f1, content=偏重的研究方向：免疫;炎症因子;炎症 经验分享：今天2月11提交，看最近审稿速度特别难，想撤回了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqxL5D7g0iavzgzVMAxGTwjDNAibA7gyiaVM1c9P2Micib6Vqc8WYJfoiceyGMQsLeOZmtWfdR8m7B8kX0Q/132, createdBy=8a142381452, createdName=秋秋_, createdTime=Sun Feb 11 18:38:02 CST 2024, time=2024-02-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2117270, encodeId=d72b211e270ad, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：免疫;炎症 经验分享：昨天收到接收函，终于可以毕业啦 一审：16天给了1个月的修改时间，一个审稿人，提了五个问题 二审：15天 完成审稿后：4天接受 感谢这个杂志，让我硕士毕业，也让我博士毕业 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=730a2343072, createdName=12295a36m78(暂无昵称), createdTime=Thu Mar 02 19:21:59 CST 2023, time=2023-03-02, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2175274, encodeId=8f6621e527489, content=偏重的研究方向：药物 经验分享：10.17一审 11.28大修 12.12修回 12.13小修 12.14修回 12.15接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=326e2255671, createdName=WWW9450, createdTime=Sat Dec 16 14:09:55 CST 2023, time=2023-12-16, status=1, ipAttribution=山东省)]

2024-01-18 ms9000001327347856 来自香港

审稿速度:6.0 | 投稿命中率:25.0
偏重的研究方向：胃癌;肿瘤免疫
经验分享：这个杂志真的好慢好慢，外审一个月，大修一个月，修回with editor一整个月，然后又送外审，十几天，RRC两周了，还没消息，等的我花都谢了。。。。。

253 7

展开7条回复

[GetPortalCommentsPageByObjectIdResponse(id=2182438, encodeId=a56c21824388d, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：胃癌;肿瘤免疫 经验分享：这个杂志真的好慢好慢，外审一个月，大修一个月，修回with editor一整个月，然后又送外审，十几天，RRC两周了，还没消息，等的我花都谢了。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=253, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11f06507596, createdName=ms9000001327347856, createdTime=Thu Jan 18 15:39:11 CST 2024, time=2024-01-18, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2103457, encodeId=1bd8210345ee0, content=2022.9.27 提交 2022.9.30 外审中间日期变了几次 2022.10.29 大修给了六十多条意见，但是都不是特别犀利 2022.11.13 修回再次under review 2022.11.28 接收 很nice的期刊，速度快，编辑人也很友善, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b6a8289282, createdName=ms5000001856769052, createdTime=Wed Nov 30 09:54:09 CST 2022, time=2022-11-30, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=590348, encodeId=89cf590348da, content=请问提供了原始wb图片了吗？怎么处理的？ lekai726 2020-04-03 发表:: 接收率：约50% 审稿时间：约2个月很快，我可能是高分低投了，因为赶时间毕业，四五分的文章内容所以也没提太多问题，一个月就接收了，另外说下编辑，真的人超级好，对中国人非常好lekai726 2020-04-03 00:00:00 发表: 很快，我可能是高分低投了，因为赶时间毕业，四五分的文章内容所以也没提太多问题，一个月就接收了，另外说下编辑，真的人超级好，对中国人非常好, beContent=lekai726 2020-04-03 发表:: 接收率：约50% 审稿时间：约2个月很快，我可能是高分低投了，因为赶时间毕业，四五分的文章内容所以也没提太多问题，一个月就接收了，另外说下编辑，真的人超级好，对中国人非常好, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=32b75167275, createdName=146cc187m12暂无昵称, createdTime=Wed May 06 00:00:00 CST 2020, time=2020-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207706, encodeId=b603120e706b0, content=被预警了，要摘星了，IF要涨了，不好投了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e6935111920, createdName=14618cfam12暂无昵称, createdTime=Fri Apr 01 00:07:27 CST 2022, time=2022-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2201187, encodeId=53f9220118e8e, content=2024-03-26投稿 03-26 with editor 03-26 under review 03-28 under review 有一个审稿人接受审稿 04-15 under review 有一个审稿人完成审稿 编辑没有再邀请审稿人，是否能催一下？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2448342932, createdName=ms9000000167770666, createdTime=Tue Apr 30 09:01:21 CST 2024, time=2024-04-30, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2170197, encodeId=1dd921e019749, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：免疫;炎症 经验分享：10.05投稿 10.11送审 10.26审稿人完成审稿 10.31给出大修 11.05修回 11.15审稿人完成审稿 11.16接收 11.19清样 10.22在线发表来还愿啦！效率很高的一个杂志，编辑和两位审稿人都很友好。修改后文章整体水平提升很大。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/YConHRH5GCtcFEWO7xCkB10VsePH8PlzvattQoVRIQ7KJg26g6PvbkD8nE6Gsic5Nub2HzA4TsvkTQqEYUoz7pw/132, createdBy=288f2160779, createdName=liyu5975, createdTime=Wed Nov 22 11:16:56 CST 2023, time=2023-11-22, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2185279, encodeId=f3ae21852e9df, content=之前投过一次，带着返修意见被拒了，补了一些实验 重新又投了 Nov 29, 2023 Submission Nov 29, 2023 With Editor Dec 04, 2023 Under Review Dec 22, 2023 Major Revise Jan 10, 2024 Submission Jan 10, 2024 Under Review Jan 18, 2024 Completed-Accept 祝大家好运！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3bc32405040, createdName=12362582m11(暂无昵称), createdTime=Thu Feb 01 19:11:16 CST 2024, time=2024-02-01, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2186928, encodeId=2e112186928f1, content=偏重的研究方向：免疫;炎症因子;炎症 经验分享：今天2月11提交，看最近审稿速度特别难，想撤回了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqxL5D7g0iavzgzVMAxGTwjDNAibA7gyiaVM1c9P2Micib6Vqc8WYJfoiceyGMQsLeOZmtWfdR8m7B8kX0Q/132, createdBy=8a142381452, createdName=秋秋_, createdTime=Sun Feb 11 18:38:02 CST 2024, time=2024-02-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2117270, encodeId=d72b211e270ad, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：免疫;炎症 经验分享：昨天收到接收函，终于可以毕业啦 一审：16天给了1个月的修改时间，一个审稿人，提了五个问题 二审：15天 完成审稿后：4天接受 感谢这个杂志，让我硕士毕业，也让我博士毕业 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=730a2343072, createdName=12295a36m78(暂无昵称), createdTime=Thu Mar 02 19:21:59 CST 2023, time=2023-03-02, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2175274, encodeId=8f6621e527489, content=偏重的研究方向：药物 经验分享：10.17一审 11.28大修 12.12修回 12.13小修 12.14修回 12.15接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=326e2255671, createdName=WWW9450, createdTime=Sat Dec 16 14:09:55 CST 2023, time=2023-12-16, status=1, ipAttribution=山东省)]

2022-11-30 ms5000001856769052 来自北京

2022.9.27 提交
2022.9.30 外审中间日期变了几次
2022.10.29 大修给了六十多条意见，但是都不是特别犀利
2022.11.13 修回再次under review
2022.11.28 接收
很nice的期刊，速度快，编辑人也很友善

58 7

展开7条回复

[GetPortalCommentsPageByObjectIdResponse(id=2182438, encodeId=a56c21824388d, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：胃癌;肿瘤免疫 经验分享：这个杂志真的好慢好慢，外审一个月，大修一个月，修回with editor一整个月，然后又送外审，十几天，RRC两周了，还没消息，等的我花都谢了。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=253, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11f06507596, createdName=ms9000001327347856, createdTime=Thu Jan 18 15:39:11 CST 2024, time=2024-01-18, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2103457, encodeId=1bd8210345ee0, content=2022.9.27 提交 2022.9.30 外审中间日期变了几次 2022.10.29 大修给了六十多条意见，但是都不是特别犀利 2022.11.13 修回再次under review 2022.11.28 接收 很nice的期刊，速度快，编辑人也很友善, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b6a8289282, createdName=ms5000001856769052, createdTime=Wed Nov 30 09:54:09 CST 2022, time=2022-11-30, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=590348, encodeId=89cf590348da, content=请问提供了原始wb图片了吗？怎么处理的？ lekai726 2020-04-03 发表:: 接收率：约50% 审稿时间：约2个月很快，我可能是高分低投了，因为赶时间毕业，四五分的文章内容所以也没提太多问题，一个月就接收了，另外说下编辑，真的人超级好，对中国人非常好lekai726 2020-04-03 00:00:00 发表: 很快，我可能是高分低投了，因为赶时间毕业，四五分的文章内容所以也没提太多问题，一个月就接收了，另外说下编辑，真的人超级好，对中国人非常好, beContent=lekai726 2020-04-03 发表:: 接收率：约50% 审稿时间：约2个月很快，我可能是高分低投了，因为赶时间毕业，四五分的文章内容所以也没提太多问题，一个月就接收了，另外说下编辑，真的人超级好，对中国人非常好, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=32b75167275, createdName=146cc187m12暂无昵称, createdTime=Wed May 06 00:00:00 CST 2020, time=2020-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207706, encodeId=b603120e706b0, content=被预警了，要摘星了，IF要涨了，不好投了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e6935111920, createdName=14618cfam12暂无昵称, createdTime=Fri Apr 01 00:07:27 CST 2022, time=2022-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2201187, encodeId=53f9220118e8e, content=2024-03-26投稿 03-26 with editor 03-26 under review 03-28 under review 有一个审稿人接受审稿 04-15 under review 有一个审稿人完成审稿 编辑没有再邀请审稿人，是否能催一下？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2448342932, createdName=ms9000000167770666, createdTime=Tue Apr 30 09:01:21 CST 2024, time=2024-04-30, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2170197, encodeId=1dd921e019749, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：免疫;炎症 经验分享：10.05投稿 10.11送审 10.26审稿人完成审稿 10.31给出大修 11.05修回 11.15审稿人完成审稿 11.16接收 11.19清样 10.22在线发表来还愿啦！效率很高的一个杂志，编辑和两位审稿人都很友好。修改后文章整体水平提升很大。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/YConHRH5GCtcFEWO7xCkB10VsePH8PlzvattQoVRIQ7KJg26g6PvbkD8nE6Gsic5Nub2HzA4TsvkTQqEYUoz7pw/132, createdBy=288f2160779, createdName=liyu5975, createdTime=Wed Nov 22 11:16:56 CST 2023, time=2023-11-22, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2185279, encodeId=f3ae21852e9df, content=之前投过一次，带着返修意见被拒了，补了一些实验 重新又投了 Nov 29, 2023 Submission Nov 29, 2023 With Editor Dec 04, 2023 Under Review Dec 22, 2023 Major Revise Jan 10, 2024 Submission Jan 10, 2024 Under Review Jan 18, 2024 Completed-Accept 祝大家好运！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3bc32405040, createdName=12362582m11(暂无昵称), createdTime=Thu Feb 01 19:11:16 CST 2024, time=2024-02-01, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2186928, encodeId=2e112186928f1, content=偏重的研究方向：免疫;炎症因子;炎症 经验分享：今天2月11提交，看最近审稿速度特别难，想撤回了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqxL5D7g0iavzgzVMAxGTwjDNAibA7gyiaVM1c9P2Micib6Vqc8WYJfoiceyGMQsLeOZmtWfdR8m7B8kX0Q/132, createdBy=8a142381452, createdName=秋秋_, createdTime=Sun Feb 11 18:38:02 CST 2024, time=2024-02-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2117270, encodeId=d72b211e270ad, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：免疫;炎症 经验分享：昨天收到接收函，终于可以毕业啦 一审：16天给了1个月的修改时间，一个审稿人，提了五个问题 二审：15天 完成审稿后：4天接受 感谢这个杂志，让我硕士毕业，也让我博士毕业 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=730a2343072, createdName=12295a36m78(暂无昵称), createdTime=Thu Mar 02 19:21:59 CST 2023, time=2023-03-02, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2175274, encodeId=8f6621e527489, content=偏重的研究方向：药物 经验分享：10.17一审 11.28大修 12.12修回 12.13小修 12.14修回 12.15接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=326e2255671, createdName=WWW9450, createdTime=Sat Dec 16 14:09:55 CST 2023, time=2023-12-16, status=1, ipAttribution=山东省)]

2020-05-06 146cc187m12暂无昵称

请问提供了原始wb图片了吗？怎么处理的？ lekai726 2020-04-03 发表::
接收率：约50% 审稿时间：约2个月很快，我可能是高分低投了，因为赶时间毕业，四五分的文章内容所以也没提太多问题，一个月就接收了，另外说下编辑，真的人超级好，对中国人非常好lekai726 2020-04-03 00:00:00 发表:
很快，我可能是高分低投了，因为赶时间毕业，四五分的文章内容所以也没提太多问题，一个月就接收了，另外说下编辑，真的人超级好，对中国人非常好

lekai726 2020-04-03 发表:: 接收率：约50% 审稿时间：约2个月很快，我可能是高分低投了，因为赶时间毕业，四五分的文章内容所以也没提太多问题，一个月就接收了，另外说下编辑，真的人超级好，对中国人非常好

149 7

展开7条回复

[GetPortalCommentsPageByObjectIdResponse(id=2182438, encodeId=a56c21824388d, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：胃癌;肿瘤免疫 经验分享：这个杂志真的好慢好慢，外审一个月，大修一个月，修回with editor一整个月，然后又送外审，十几天，RRC两周了，还没消息，等的我花都谢了。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=253, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11f06507596, createdName=ms9000001327347856, createdTime=Thu Jan 18 15:39:11 CST 2024, time=2024-01-18, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2103457, encodeId=1bd8210345ee0, content=2022.9.27 提交 2022.9.30 外审中间日期变了几次 2022.10.29 大修给了六十多条意见，但是都不是特别犀利 2022.11.13 修回再次under review 2022.11.28 接收 很nice的期刊，速度快，编辑人也很友善, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b6a8289282, createdName=ms5000001856769052, createdTime=Wed Nov 30 09:54:09 CST 2022, time=2022-11-30, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=590348, encodeId=89cf590348da, content=请问提供了原始wb图片了吗？怎么处理的？ lekai726 2020-04-03 发表:: 接收率：约50% 审稿时间：约2个月很快，我可能是高分低投了，因为赶时间毕业，四五分的文章内容所以也没提太多问题，一个月就接收了，另外说下编辑，真的人超级好，对中国人非常好lekai726 2020-04-03 00:00:00 发表: 很快，我可能是高分低投了，因为赶时间毕业，四五分的文章内容所以也没提太多问题，一个月就接收了，另外说下编辑，真的人超级好，对中国人非常好, beContent=lekai726 2020-04-03 发表:: 接收率：约50% 审稿时间：约2个月很快，我可能是高分低投了，因为赶时间毕业，四五分的文章内容所以也没提太多问题，一个月就接收了，另外说下编辑，真的人超级好，对中国人非常好, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=32b75167275, createdName=146cc187m12暂无昵称, createdTime=Wed May 06 00:00:00 CST 2020, time=2020-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207706, encodeId=b603120e706b0, content=被预警了，要摘星了，IF要涨了，不好投了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e6935111920, createdName=14618cfam12暂无昵称, createdTime=Fri Apr 01 00:07:27 CST 2022, time=2022-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2201187, encodeId=53f9220118e8e, content=2024-03-26投稿 03-26 with editor 03-26 under review 03-28 under review 有一个审稿人接受审稿 04-15 under review 有一个审稿人完成审稿 编辑没有再邀请审稿人，是否能催一下？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2448342932, createdName=ms9000000167770666, createdTime=Tue Apr 30 09:01:21 CST 2024, time=2024-04-30, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2170197, encodeId=1dd921e019749, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：免疫;炎症 经验分享：10.05投稿 10.11送审 10.26审稿人完成审稿 10.31给出大修 11.05修回 11.15审稿人完成审稿 11.16接收 11.19清样 10.22在线发表来还愿啦！效率很高的一个杂志，编辑和两位审稿人都很友好。修改后文章整体水平提升很大。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/YConHRH5GCtcFEWO7xCkB10VsePH8PlzvattQoVRIQ7KJg26g6PvbkD8nE6Gsic5Nub2HzA4TsvkTQqEYUoz7pw/132, createdBy=288f2160779, createdName=liyu5975, createdTime=Wed Nov 22 11:16:56 CST 2023, time=2023-11-22, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2185279, encodeId=f3ae21852e9df, content=之前投过一次，带着返修意见被拒了，补了一些实验 重新又投了 Nov 29, 2023 Submission Nov 29, 2023 With Editor Dec 04, 2023 Under Review Dec 22, 2023 Major Revise Jan 10, 2024 Submission Jan 10, 2024 Under Review Jan 18, 2024 Completed-Accept 祝大家好运！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3bc32405040, createdName=12362582m11(暂无昵称), createdTime=Thu Feb 01 19:11:16 CST 2024, time=2024-02-01, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2186928, encodeId=2e112186928f1, content=偏重的研究方向：免疫;炎症因子;炎症 经验分享：今天2月11提交，看最近审稿速度特别难，想撤回了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqxL5D7g0iavzgzVMAxGTwjDNAibA7gyiaVM1c9P2Micib6Vqc8WYJfoiceyGMQsLeOZmtWfdR8m7B8kX0Q/132, createdBy=8a142381452, createdName=秋秋_, createdTime=Sun Feb 11 18:38:02 CST 2024, time=2024-02-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2117270, encodeId=d72b211e270ad, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：免疫;炎症 经验分享：昨天收到接收函，终于可以毕业啦 一审：16天给了1个月的修改时间，一个审稿人，提了五个问题 二审：15天 完成审稿后：4天接受 感谢这个杂志，让我硕士毕业，也让我博士毕业 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=730a2343072, createdName=12295a36m78(暂无昵称), createdTime=Thu Mar 02 19:21:59 CST 2023, time=2023-03-02, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2175274, encodeId=8f6621e527489, content=偏重的研究方向：药物 经验分享：10.17一审 11.28大修 12.12修回 12.13小修 12.14修回 12.15接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=326e2255671, createdName=WWW9450, createdTime=Sat Dec 16 14:09:55 CST 2023, time=2023-12-16, status=1, ipAttribution=山东省)]

2022-04-01 14618cfam12暂无昵称

被预警了，要摘星了，IF要涨了，不好投了

52 7

展开7条回复

[GetPortalCommentsPageByObjectIdResponse(id=2182438, encodeId=a56c21824388d, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：胃癌;肿瘤免疫 经验分享：这个杂志真的好慢好慢，外审一个月，大修一个月，修回with editor一整个月，然后又送外审，十几天，RRC两周了，还没消息，等的我花都谢了。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=253, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11f06507596, createdName=ms9000001327347856, createdTime=Thu Jan 18 15:39:11 CST 2024, time=2024-01-18, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2103457, encodeId=1bd8210345ee0, content=2022.9.27 提交 2022.9.30 外审中间日期变了几次 2022.10.29 大修给了六十多条意见，但是都不是特别犀利 2022.11.13 修回再次under review 2022.11.28 接收 很nice的期刊，速度快，编辑人也很友善, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b6a8289282, createdName=ms5000001856769052, createdTime=Wed Nov 30 09:54:09 CST 2022, time=2022-11-30, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=590348, encodeId=89cf590348da, content=请问提供了原始wb图片了吗？怎么处理的？ lekai726 2020-04-03 发表:: 接收率：约50% 审稿时间：约2个月很快，我可能是高分低投了，因为赶时间毕业，四五分的文章内容所以也没提太多问题，一个月就接收了，另外说下编辑，真的人超级好，对中国人非常好lekai726 2020-04-03 00:00:00 发表: 很快，我可能是高分低投了，因为赶时间毕业，四五分的文章内容所以也没提太多问题，一个月就接收了，另外说下编辑，真的人超级好，对中国人非常好, beContent=lekai726 2020-04-03 发表:: 接收率：约50% 审稿时间：约2个月很快，我可能是高分低投了，因为赶时间毕业，四五分的文章内容所以也没提太多问题，一个月就接收了，另外说下编辑，真的人超级好，对中国人非常好, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=32b75167275, createdName=146cc187m12暂无昵称, createdTime=Wed May 06 00:00:00 CST 2020, time=2020-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207706, encodeId=b603120e706b0, content=被预警了，要摘星了，IF要涨了，不好投了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e6935111920, createdName=14618cfam12暂无昵称, createdTime=Fri Apr 01 00:07:27 CST 2022, time=2022-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2201187, encodeId=53f9220118e8e, content=2024-03-26投稿 03-26 with editor 03-26 under review 03-28 under review 有一个审稿人接受审稿 04-15 under review 有一个审稿人完成审稿 编辑没有再邀请审稿人，是否能催一下？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2448342932, createdName=ms9000000167770666, createdTime=Tue Apr 30 09:01:21 CST 2024, time=2024-04-30, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2170197, encodeId=1dd921e019749, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：免疫;炎症 经验分享：10.05投稿 10.11送审 10.26审稿人完成审稿 10.31给出大修 11.05修回 11.15审稿人完成审稿 11.16接收 11.19清样 10.22在线发表来还愿啦！效率很高的一个杂志，编辑和两位审稿人都很友好。修改后文章整体水平提升很大。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/YConHRH5GCtcFEWO7xCkB10VsePH8PlzvattQoVRIQ7KJg26g6PvbkD8nE6Gsic5Nub2HzA4TsvkTQqEYUoz7pw/132, createdBy=288f2160779, createdName=liyu5975, createdTime=Wed Nov 22 11:16:56 CST 2023, time=2023-11-22, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2185279, encodeId=f3ae21852e9df, content=之前投过一次，带着返修意见被拒了，补了一些实验 重新又投了 Nov 29, 2023 Submission Nov 29, 2023 With Editor Dec 04, 2023 Under Review Dec 22, 2023 Major Revise Jan 10, 2024 Submission Jan 10, 2024 Under Review Jan 18, 2024 Completed-Accept 祝大家好运！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3bc32405040, createdName=12362582m11(暂无昵称), createdTime=Thu Feb 01 19:11:16 CST 2024, time=2024-02-01, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2186928, encodeId=2e112186928f1, content=偏重的研究方向：免疫;炎症因子;炎症 经验分享：今天2月11提交，看最近审稿速度特别难，想撤回了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqxL5D7g0iavzgzVMAxGTwjDNAibA7gyiaVM1c9P2Micib6Vqc8WYJfoiceyGMQsLeOZmtWfdR8m7B8kX0Q/132, createdBy=8a142381452, createdName=秋秋_, createdTime=Sun Feb 11 18:38:02 CST 2024, time=2024-02-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2117270, encodeId=d72b211e270ad, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：免疫;炎症 经验分享：昨天收到接收函，终于可以毕业啦 一审：16天给了1个月的修改时间，一个审稿人，提了五个问题 二审：15天 完成审稿后：4天接受 感谢这个杂志，让我硕士毕业，也让我博士毕业 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=730a2343072, createdName=12295a36m78(暂无昵称), createdTime=Thu Mar 02 19:21:59 CST 2023, time=2023-03-02, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2175274, encodeId=8f6621e527489, content=偏重的研究方向：药物 经验分享：10.17一审 11.28大修 12.12修回 12.13小修 12.14修回 12.15接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=326e2255671, createdName=WWW9450, createdTime=Sat Dec 16 14:09:55 CST 2023, time=2023-12-16, status=1, ipAttribution=山东省)]

2024-04-30 ms9000000167770666 来自新疆

2024-03-26投稿
03-26 with editor
03-26 under review
03-28 under review 有一个审稿人接受审稿
04-15 under review 有一个审稿人完成审稿
编辑没有再邀请审稿人，是否能催一下？

14 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=2182438, encodeId=a56c21824388d, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：胃癌;肿瘤免疫 经验分享：这个杂志真的好慢好慢，外审一个月，大修一个月，修回with editor一整个月，然后又送外审，十几天，RRC两周了，还没消息，等的我花都谢了。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=253, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11f06507596, createdName=ms9000001327347856, createdTime=Thu Jan 18 15:39:11 CST 2024, time=2024-01-18, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2103457, encodeId=1bd8210345ee0, content=2022.9.27 提交 2022.9.30 外审中间日期变了几次 2022.10.29 大修给了六十多条意见，但是都不是特别犀利 2022.11.13 修回再次under review 2022.11.28 接收 很nice的期刊，速度快，编辑人也很友善, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b6a8289282, createdName=ms5000001856769052, createdTime=Wed Nov 30 09:54:09 CST 2022, time=2022-11-30, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=590348, encodeId=89cf590348da, content=请问提供了原始wb图片了吗？怎么处理的？ lekai726 2020-04-03 发表:: 接收率：约50% 审稿时间：约2个月很快，我可能是高分低投了，因为赶时间毕业，四五分的文章内容所以也没提太多问题，一个月就接收了，另外说下编辑，真的人超级好，对中国人非常好lekai726 2020-04-03 00:00:00 发表: 很快，我可能是高分低投了，因为赶时间毕业，四五分的文章内容所以也没提太多问题，一个月就接收了，另外说下编辑，真的人超级好，对中国人非常好, beContent=lekai726 2020-04-03 发表:: 接收率：约50% 审稿时间：约2个月很快，我可能是高分低投了，因为赶时间毕业，四五分的文章内容所以也没提太多问题，一个月就接收了，另外说下编辑，真的人超级好，对中国人非常好, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=32b75167275, createdName=146cc187m12暂无昵称, createdTime=Wed May 06 00:00:00 CST 2020, time=2020-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207706, encodeId=b603120e706b0, content=被预警了，要摘星了，IF要涨了，不好投了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e6935111920, createdName=14618cfam12暂无昵称, createdTime=Fri Apr 01 00:07:27 CST 2022, time=2022-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2201187, encodeId=53f9220118e8e, content=2024-03-26投稿 03-26 with editor 03-26 under review 03-28 under review 有一个审稿人接受审稿 04-15 under review 有一个审稿人完成审稿 编辑没有再邀请审稿人，是否能催一下？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2448342932, createdName=ms9000000167770666, createdTime=Tue Apr 30 09:01:21 CST 2024, time=2024-04-30, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2170197, encodeId=1dd921e019749, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：免疫;炎症 经验分享：10.05投稿 10.11送审 10.26审稿人完成审稿 10.31给出大修 11.05修回 11.15审稿人完成审稿 11.16接收 11.19清样 10.22在线发表来还愿啦！效率很高的一个杂志，编辑和两位审稿人都很友好。修改后文章整体水平提升很大。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/YConHRH5GCtcFEWO7xCkB10VsePH8PlzvattQoVRIQ7KJg26g6PvbkD8nE6Gsic5Nub2HzA4TsvkTQqEYUoz7pw/132, createdBy=288f2160779, createdName=liyu5975, createdTime=Wed Nov 22 11:16:56 CST 2023, time=2023-11-22, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2185279, encodeId=f3ae21852e9df, content=之前投过一次，带着返修意见被拒了，补了一些实验 重新又投了 Nov 29, 2023 Submission Nov 29, 2023 With Editor Dec 04, 2023 Under Review Dec 22, 2023 Major Revise Jan 10, 2024 Submission Jan 10, 2024 Under Review Jan 18, 2024 Completed-Accept 祝大家好运！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3bc32405040, createdName=12362582m11(暂无昵称), createdTime=Thu Feb 01 19:11:16 CST 2024, time=2024-02-01, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2186928, encodeId=2e112186928f1, content=偏重的研究方向：免疫;炎症因子;炎症 经验分享：今天2月11提交，看最近审稿速度特别难，想撤回了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqxL5D7g0iavzgzVMAxGTwjDNAibA7gyiaVM1c9P2Micib6Vqc8WYJfoiceyGMQsLeOZmtWfdR8m7B8kX0Q/132, createdBy=8a142381452, createdName=秋秋_, createdTime=Sun Feb 11 18:38:02 CST 2024, time=2024-02-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2117270, encodeId=d72b211e270ad, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：免疫;炎症 经验分享：昨天收到接收函，终于可以毕业啦 一审：16天给了1个月的修改时间，一个审稿人，提了五个问题 二审：15天 完成审稿后：4天接受 感谢这个杂志，让我硕士毕业，也让我博士毕业 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=730a2343072, createdName=12295a36m78(暂无昵称), createdTime=Thu Mar 02 19:21:59 CST 2023, time=2023-03-02, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2175274, encodeId=8f6621e527489, content=偏重的研究方向：药物 经验分享：10.17一审 11.28大修 12.12修回 12.13小修 12.14修回 12.15接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=326e2255671, createdName=WWW9450, createdTime=Sat Dec 16 14:09:55 CST 2023, time=2023-12-16, status=1, ipAttribution=山东省)]

2023-11-22 liyu5975 来自陕西省

审稿速度:1.0 | 投稿命中率:50.0
偏重的研究方向：免疫;炎症
经验分享：10.05投稿 10.11送审 10.26审稿人完成审稿 10.31给出大修 11.05修回 11.15审稿人完成审稿 11.16接收 11.19清样 10.22在线发表来还愿啦！效率很高的一个杂志，编辑和两位审稿人都很友好。修改后文章整体水平提升很大。

33 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=2182438, encodeId=a56c21824388d, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：胃癌;肿瘤免疫 经验分享：这个杂志真的好慢好慢，外审一个月，大修一个月，修回with editor一整个月，然后又送外审，十几天，RRC两周了，还没消息，等的我花都谢了。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=253, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11f06507596, createdName=ms9000001327347856, createdTime=Thu Jan 18 15:39:11 CST 2024, time=2024-01-18, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2103457, encodeId=1bd8210345ee0, content=2022.9.27 提交 2022.9.30 外审中间日期变了几次 2022.10.29 大修给了六十多条意见，但是都不是特别犀利 2022.11.13 修回再次under review 2022.11.28 接收 很nice的期刊，速度快，编辑人也很友善, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b6a8289282, createdName=ms5000001856769052, createdTime=Wed Nov 30 09:54:09 CST 2022, time=2022-11-30, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=590348, encodeId=89cf590348da, content=请问提供了原始wb图片了吗？怎么处理的？ lekai726 2020-04-03 发表:: 接收率：约50% 审稿时间：约2个月很快，我可能是高分低投了，因为赶时间毕业，四五分的文章内容所以也没提太多问题，一个月就接收了，另外说下编辑，真的人超级好，对中国人非常好lekai726 2020-04-03 00:00:00 发表: 很快，我可能是高分低投了，因为赶时间毕业，四五分的文章内容所以也没提太多问题，一个月就接收了，另外说下编辑，真的人超级好，对中国人非常好, beContent=lekai726 2020-04-03 发表:: 接收率：约50% 审稿时间：约2个月很快，我可能是高分低投了，因为赶时间毕业，四五分的文章内容所以也没提太多问题，一个月就接收了，另外说下编辑，真的人超级好，对中国人非常好, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=32b75167275, createdName=146cc187m12暂无昵称, createdTime=Wed May 06 00:00:00 CST 2020, time=2020-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207706, encodeId=b603120e706b0, content=被预警了，要摘星了，IF要涨了，不好投了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e6935111920, createdName=14618cfam12暂无昵称, createdTime=Fri Apr 01 00:07:27 CST 2022, time=2022-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2201187, encodeId=53f9220118e8e, content=2024-03-26投稿 03-26 with editor 03-26 under review 03-28 under review 有一个审稿人接受审稿 04-15 under review 有一个审稿人完成审稿 编辑没有再邀请审稿人，是否能催一下？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2448342932, createdName=ms9000000167770666, createdTime=Tue Apr 30 09:01:21 CST 2024, time=2024-04-30, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2170197, encodeId=1dd921e019749, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：免疫;炎症 经验分享：10.05投稿 10.11送审 10.26审稿人完成审稿 10.31给出大修 11.05修回 11.15审稿人完成审稿 11.16接收 11.19清样 10.22在线发表来还愿啦！效率很高的一个杂志，编辑和两位审稿人都很友好。修改后文章整体水平提升很大。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/YConHRH5GCtcFEWO7xCkB10VsePH8PlzvattQoVRIQ7KJg26g6PvbkD8nE6Gsic5Nub2HzA4TsvkTQqEYUoz7pw/132, createdBy=288f2160779, createdName=liyu5975, createdTime=Wed Nov 22 11:16:56 CST 2023, time=2023-11-22, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2185279, encodeId=f3ae21852e9df, content=之前投过一次，带着返修意见被拒了，补了一些实验 重新又投了 Nov 29, 2023 Submission Nov 29, 2023 With Editor Dec 04, 2023 Under Review Dec 22, 2023 Major Revise Jan 10, 2024 Submission Jan 10, 2024 Under Review Jan 18, 2024 Completed-Accept 祝大家好运！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3bc32405040, createdName=12362582m11(暂无昵称), createdTime=Thu Feb 01 19:11:16 CST 2024, time=2024-02-01, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2186928, encodeId=2e112186928f1, content=偏重的研究方向：免疫;炎症因子;炎症 经验分享：今天2月11提交，看最近审稿速度特别难，想撤回了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqxL5D7g0iavzgzVMAxGTwjDNAibA7gyiaVM1c9P2Micib6Vqc8WYJfoiceyGMQsLeOZmtWfdR8m7B8kX0Q/132, createdBy=8a142381452, createdName=秋秋_, createdTime=Sun Feb 11 18:38:02 CST 2024, time=2024-02-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2117270, encodeId=d72b211e270ad, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：免疫;炎症 经验分享：昨天收到接收函，终于可以毕业啦 一审：16天给了1个月的修改时间，一个审稿人，提了五个问题 二审：15天 完成审稿后：4天接受 感谢这个杂志，让我硕士毕业，也让我博士毕业 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=730a2343072, createdName=12295a36m78(暂无昵称), createdTime=Thu Mar 02 19:21:59 CST 2023, time=2023-03-02, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2175274, encodeId=8f6621e527489, content=偏重的研究方向：药物 经验分享：10.17一审 11.28大修 12.12修回 12.13小修 12.14修回 12.15接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=326e2255671, createdName=WWW9450, createdTime=Sat Dec 16 14:09:55 CST 2023, time=2023-12-16, status=1, ipAttribution=山东省)]

2024-02-01 12362582m11(暂无昵称) 来自上海

之前投过一次，带着返修意见被拒了，补了一些实验
重新又投了
Nov 29, 2023 Submission
Nov 29, 2023 With Editor
Dec 04, 2023 Under Review
Dec 22, 2023 Major Revise
Jan 10, 2024 Submission
Jan 10, 2024 Under Review
Jan 18, 2024 Completed-Accept
祝大家好运！

33 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=2182438, encodeId=a56c21824388d, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：胃癌;肿瘤免疫 经验分享：这个杂志真的好慢好慢，外审一个月，大修一个月，修回with editor一整个月，然后又送外审，十几天，RRC两周了，还没消息，等的我花都谢了。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=253, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11f06507596, createdName=ms9000001327347856, createdTime=Thu Jan 18 15:39:11 CST 2024, time=2024-01-18, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2103457, encodeId=1bd8210345ee0, content=2022.9.27 提交 2022.9.30 外审中间日期变了几次 2022.10.29 大修给了六十多条意见，但是都不是特别犀利 2022.11.13 修回再次under review 2022.11.28 接收 很nice的期刊，速度快，编辑人也很友善, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b6a8289282, createdName=ms5000001856769052, createdTime=Wed Nov 30 09:54:09 CST 2022, time=2022-11-30, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=590348, encodeId=89cf590348da, content=请问提供了原始wb图片了吗？怎么处理的？ lekai726 2020-04-03 发表:: 接收率：约50% 审稿时间：约2个月很快，我可能是高分低投了，因为赶时间毕业，四五分的文章内容所以也没提太多问题，一个月就接收了，另外说下编辑，真的人超级好，对中国人非常好lekai726 2020-04-03 00:00:00 发表: 很快，我可能是高分低投了，因为赶时间毕业，四五分的文章内容所以也没提太多问题，一个月就接收了，另外说下编辑，真的人超级好，对中国人非常好, beContent=lekai726 2020-04-03 发表:: 接收率：约50% 审稿时间：约2个月很快，我可能是高分低投了，因为赶时间毕业，四五分的文章内容所以也没提太多问题，一个月就接收了，另外说下编辑，真的人超级好，对中国人非常好, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=32b75167275, createdName=146cc187m12暂无昵称, createdTime=Wed May 06 00:00:00 CST 2020, time=2020-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207706, encodeId=b603120e706b0, content=被预警了，要摘星了，IF要涨了，不好投了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e6935111920, createdName=14618cfam12暂无昵称, createdTime=Fri Apr 01 00:07:27 CST 2022, time=2022-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2201187, encodeId=53f9220118e8e, content=2024-03-26投稿 03-26 with editor 03-26 under review 03-28 under review 有一个审稿人接受审稿 04-15 under review 有一个审稿人完成审稿 编辑没有再邀请审稿人，是否能催一下？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2448342932, createdName=ms9000000167770666, createdTime=Tue Apr 30 09:01:21 CST 2024, time=2024-04-30, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2170197, encodeId=1dd921e019749, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：免疫;炎症 经验分享：10.05投稿 10.11送审 10.26审稿人完成审稿 10.31给出大修 11.05修回 11.15审稿人完成审稿 11.16接收 11.19清样 10.22在线发表来还愿啦！效率很高的一个杂志，编辑和两位审稿人都很友好。修改后文章整体水平提升很大。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/YConHRH5GCtcFEWO7xCkB10VsePH8PlzvattQoVRIQ7KJg26g6PvbkD8nE6Gsic5Nub2HzA4TsvkTQqEYUoz7pw/132, createdBy=288f2160779, createdName=liyu5975, createdTime=Wed Nov 22 11:16:56 CST 2023, time=2023-11-22, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2185279, encodeId=f3ae21852e9df, content=之前投过一次，带着返修意见被拒了，补了一些实验 重新又投了 Nov 29, 2023 Submission Nov 29, 2023 With Editor Dec 04, 2023 Under Review Dec 22, 2023 Major Revise Jan 10, 2024 Submission Jan 10, 2024 Under Review Jan 18, 2024 Completed-Accept 祝大家好运！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3bc32405040, createdName=12362582m11(暂无昵称), createdTime=Thu Feb 01 19:11:16 CST 2024, time=2024-02-01, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2186928, encodeId=2e112186928f1, content=偏重的研究方向：免疫;炎症因子;炎症 经验分享：今天2月11提交，看最近审稿速度特别难，想撤回了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqxL5D7g0iavzgzVMAxGTwjDNAibA7gyiaVM1c9P2Micib6Vqc8WYJfoiceyGMQsLeOZmtWfdR8m7B8kX0Q/132, createdBy=8a142381452, createdName=秋秋_, createdTime=Sun Feb 11 18:38:02 CST 2024, time=2024-02-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2117270, encodeId=d72b211e270ad, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：免疫;炎症 经验分享：昨天收到接收函，终于可以毕业啦 一审：16天给了1个月的修改时间，一个审稿人，提了五个问题 二审：15天 完成审稿后：4天接受 感谢这个杂志，让我硕士毕业，也让我博士毕业 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=730a2343072, createdName=12295a36m78(暂无昵称), createdTime=Thu Mar 02 19:21:59 CST 2023, time=2023-03-02, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2175274, encodeId=8f6621e527489, content=偏重的研究方向：药物 经验分享：10.17一审 11.28大修 12.12修回 12.13小修 12.14修回 12.15接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=326e2255671, createdName=WWW9450, createdTime=Sat Dec 16 14:09:55 CST 2023, time=2023-12-16, status=1, ipAttribution=山东省)]

2024-02-11 秋秋_ 来自北京

偏重的研究方向：免疫;炎症因子;炎症
经验分享：今天2月11提交，看最近审稿速度特别难，想撤回了

19 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=2182438, encodeId=a56c21824388d, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：胃癌;肿瘤免疫 经验分享：这个杂志真的好慢好慢，外审一个月，大修一个月，修回with editor一整个月，然后又送外审，十几天，RRC两周了，还没消息，等的我花都谢了。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=253, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11f06507596, createdName=ms9000001327347856, createdTime=Thu Jan 18 15:39:11 CST 2024, time=2024-01-18, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2103457, encodeId=1bd8210345ee0, content=2022.9.27 提交 2022.9.30 外审中间日期变了几次 2022.10.29 大修给了六十多条意见，但是都不是特别犀利 2022.11.13 修回再次under review 2022.11.28 接收 很nice的期刊，速度快，编辑人也很友善, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b6a8289282, createdName=ms5000001856769052, createdTime=Wed Nov 30 09:54:09 CST 2022, time=2022-11-30, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=590348, encodeId=89cf590348da, content=请问提供了原始wb图片了吗？怎么处理的？ lekai726 2020-04-03 发表:: 接收率：约50% 审稿时间：约2个月很快，我可能是高分低投了，因为赶时间毕业，四五分的文章内容所以也没提太多问题，一个月就接收了，另外说下编辑，真的人超级好，对中国人非常好lekai726 2020-04-03 00:00:00 发表: 很快，我可能是高分低投了，因为赶时间毕业，四五分的文章内容所以也没提太多问题，一个月就接收了，另外说下编辑，真的人超级好，对中国人非常好, beContent=lekai726 2020-04-03 发表:: 接收率：约50% 审稿时间：约2个月很快，我可能是高分低投了，因为赶时间毕业，四五分的文章内容所以也没提太多问题，一个月就接收了，另外说下编辑，真的人超级好，对中国人非常好, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=32b75167275, createdName=146cc187m12暂无昵称, createdTime=Wed May 06 00:00:00 CST 2020, time=2020-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207706, encodeId=b603120e706b0, content=被预警了，要摘星了，IF要涨了，不好投了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e6935111920, createdName=14618cfam12暂无昵称, createdTime=Fri Apr 01 00:07:27 CST 2022, time=2022-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2201187, encodeId=53f9220118e8e, content=2024-03-26投稿 03-26 with editor 03-26 under review 03-28 under review 有一个审稿人接受审稿 04-15 under review 有一个审稿人完成审稿 编辑没有再邀请审稿人，是否能催一下？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2448342932, createdName=ms9000000167770666, createdTime=Tue Apr 30 09:01:21 CST 2024, time=2024-04-30, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2170197, encodeId=1dd921e019749, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：免疫;炎症 经验分享：10.05投稿 10.11送审 10.26审稿人完成审稿 10.31给出大修 11.05修回 11.15审稿人完成审稿 11.16接收 11.19清样 10.22在线发表来还愿啦！效率很高的一个杂志，编辑和两位审稿人都很友好。修改后文章整体水平提升很大。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/YConHRH5GCtcFEWO7xCkB10VsePH8PlzvattQoVRIQ7KJg26g6PvbkD8nE6Gsic5Nub2HzA4TsvkTQqEYUoz7pw/132, createdBy=288f2160779, createdName=liyu5975, createdTime=Wed Nov 22 11:16:56 CST 2023, time=2023-11-22, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2185279, encodeId=f3ae21852e9df, content=之前投过一次，带着返修意见被拒了，补了一些实验 重新又投了 Nov 29, 2023 Submission Nov 29, 2023 With Editor Dec 04, 2023 Under Review Dec 22, 2023 Major Revise Jan 10, 2024 Submission Jan 10, 2024 Under Review Jan 18, 2024 Completed-Accept 祝大家好运！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3bc32405040, createdName=12362582m11(暂无昵称), createdTime=Thu Feb 01 19:11:16 CST 2024, time=2024-02-01, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2186928, encodeId=2e112186928f1, content=偏重的研究方向：免疫;炎症因子;炎症 经验分享：今天2月11提交，看最近审稿速度特别难，想撤回了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqxL5D7g0iavzgzVMAxGTwjDNAibA7gyiaVM1c9P2Micib6Vqc8WYJfoiceyGMQsLeOZmtWfdR8m7B8kX0Q/132, createdBy=8a142381452, createdName=秋秋_, createdTime=Sun Feb 11 18:38:02 CST 2024, time=2024-02-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2117270, encodeId=d72b211e270ad, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：免疫;炎症 经验分享：昨天收到接收函，终于可以毕业啦 一审：16天给了1个月的修改时间，一个审稿人，提了五个问题 二审：15天 完成审稿后：4天接受 感谢这个杂志，让我硕士毕业，也让我博士毕业 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=730a2343072, createdName=12295a36m78(暂无昵称), createdTime=Thu Mar 02 19:21:59 CST 2023, time=2023-03-02, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2175274, encodeId=8f6621e527489, content=偏重的研究方向：药物 经验分享：10.17一审 11.28大修 12.12修回 12.13小修 12.14修回 12.15接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=326e2255671, createdName=WWW9450, createdTime=Sat Dec 16 14:09:55 CST 2023, time=2023-12-16, status=1, ipAttribution=山东省)]

2023-03-02 12295a36m78(暂无昵称) 来自湖北省

审稿速度:1.0 | 投稿命中率:50.0
偏重的研究方向：免疫;炎症
经验分享：昨天收到接收函，终于可以毕业啦
一审：16天给了1个月的修改时间，一个审稿人，提了五个问题
二审：15天
完成审稿后：4天接受
感谢这个杂志，让我硕士毕业，也让我博士毕业

51 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=2182438, encodeId=a56c21824388d, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：胃癌;肿瘤免疫 经验分享：这个杂志真的好慢好慢，外审一个月，大修一个月，修回with editor一整个月，然后又送外审，十几天，RRC两周了，还没消息，等的我花都谢了。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=253, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11f06507596, createdName=ms9000001327347856, createdTime=Thu Jan 18 15:39:11 CST 2024, time=2024-01-18, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2103457, encodeId=1bd8210345ee0, content=2022.9.27 提交 2022.9.30 外审中间日期变了几次 2022.10.29 大修给了六十多条意见，但是都不是特别犀利 2022.11.13 修回再次under review 2022.11.28 接收 很nice的期刊，速度快，编辑人也很友善, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b6a8289282, createdName=ms5000001856769052, createdTime=Wed Nov 30 09:54:09 CST 2022, time=2022-11-30, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=590348, encodeId=89cf590348da, content=请问提供了原始wb图片了吗？怎么处理的？ lekai726 2020-04-03 发表:: 接收率：约50% 审稿时间：约2个月很快，我可能是高分低投了，因为赶时间毕业，四五分的文章内容所以也没提太多问题，一个月就接收了，另外说下编辑，真的人超级好，对中国人非常好lekai726 2020-04-03 00:00:00 发表: 很快，我可能是高分低投了，因为赶时间毕业，四五分的文章内容所以也没提太多问题，一个月就接收了，另外说下编辑，真的人超级好，对中国人非常好, beContent=lekai726 2020-04-03 发表:: 接收率：约50% 审稿时间：约2个月很快，我可能是高分低投了，因为赶时间毕业，四五分的文章内容所以也没提太多问题，一个月就接收了，另外说下编辑，真的人超级好，对中国人非常好, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=32b75167275, createdName=146cc187m12暂无昵称, createdTime=Wed May 06 00:00:00 CST 2020, time=2020-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207706, encodeId=b603120e706b0, content=被预警了，要摘星了，IF要涨了，不好投了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e6935111920, createdName=14618cfam12暂无昵称, createdTime=Fri Apr 01 00:07:27 CST 2022, time=2022-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2201187, encodeId=53f9220118e8e, content=2024-03-26投稿 03-26 with editor 03-26 under review 03-28 under review 有一个审稿人接受审稿 04-15 under review 有一个审稿人完成审稿 编辑没有再邀请审稿人，是否能催一下？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2448342932, createdName=ms9000000167770666, createdTime=Tue Apr 30 09:01:21 CST 2024, time=2024-04-30, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2170197, encodeId=1dd921e019749, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：免疫;炎症 经验分享：10.05投稿 10.11送审 10.26审稿人完成审稿 10.31给出大修 11.05修回 11.15审稿人完成审稿 11.16接收 11.19清样 10.22在线发表来还愿啦！效率很高的一个杂志，编辑和两位审稿人都很友好。修改后文章整体水平提升很大。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/YConHRH5GCtcFEWO7xCkB10VsePH8PlzvattQoVRIQ7KJg26g6PvbkD8nE6Gsic5Nub2HzA4TsvkTQqEYUoz7pw/132, createdBy=288f2160779, createdName=liyu5975, createdTime=Wed Nov 22 11:16:56 CST 2023, time=2023-11-22, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2185279, encodeId=f3ae21852e9df, content=之前投过一次，带着返修意见被拒了，补了一些实验 重新又投了 Nov 29, 2023 Submission Nov 29, 2023 With Editor Dec 04, 2023 Under Review Dec 22, 2023 Major Revise Jan 10, 2024 Submission Jan 10, 2024 Under Review Jan 18, 2024 Completed-Accept 祝大家好运！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3bc32405040, createdName=12362582m11(暂无昵称), createdTime=Thu Feb 01 19:11:16 CST 2024, time=2024-02-01, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2186928, encodeId=2e112186928f1, content=偏重的研究方向：免疫;炎症因子;炎症 经验分享：今天2月11提交，看最近审稿速度特别难，想撤回了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqxL5D7g0iavzgzVMAxGTwjDNAibA7gyiaVM1c9P2Micib6Vqc8WYJfoiceyGMQsLeOZmtWfdR8m7B8kX0Q/132, createdBy=8a142381452, createdName=秋秋_, createdTime=Sun Feb 11 18:38:02 CST 2024, time=2024-02-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2117270, encodeId=d72b211e270ad, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：免疫;炎症 经验分享：昨天收到接收函，终于可以毕业啦 一审：16天给了1个月的修改时间，一个审稿人，提了五个问题 二审：15天 完成审稿后：4天接受 感谢这个杂志，让我硕士毕业，也让我博士毕业 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=730a2343072, createdName=12295a36m78(暂无昵称), createdTime=Thu Mar 02 19:21:59 CST 2023, time=2023-03-02, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2175274, encodeId=8f6621e527489, content=偏重的研究方向：药物 经验分享：10.17一审 11.28大修 12.12修回 12.13小修 12.14修回 12.15接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=326e2255671, createdName=WWW9450, createdTime=Sat Dec 16 14:09:55 CST 2023, time=2023-12-16, status=1, ipAttribution=山东省)]

2023-12-16 WWW9450 来自山东省

偏重的研究方向：药物
经验分享：10.17一审 11.28大修 12.12修回 12.13小修 12.14修回 12.15接收

23 6

展开6条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务